Back to Search
Start Over
Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy.
- Source :
- OncoImmunology; Sep2014, Vol. 3 Issue 9, pN.PAG-N.PAG, 1p
- Publication Year :
- 2014
-
Abstract
- CD1d-restricted invariant natural killer T cells (iNKT) constitute an important immunoregulatory T-cell subset involved in the induction of antitumor immune responses. Here, we provide a view on the recent observation that Vγ9Vδ2-T cells, through trogocytosis of CD1d-containing membrane fragments, have the capacity to act as antigen presenting cells for iNKT. [ABSTRACT FROM AUTHOR]
- Subjects :
- IMMUNOTHERAPY
T cells
ANTIGENS
IMMUNE response
MEMBRANE proteins
Subjects
Details
- Language :
- English
- ISSN :
- 21624011
- Volume :
- 3
- Issue :
- 9
- Database :
- Complementary Index
- Journal :
- OncoImmunology
- Publication Type :
- Academic Journal
- Accession number :
- 99964403
- Full Text :
- https://doi.org/10.4161/21624011.2014.955343